OKO. V. Korytov

O. V. Korytov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


O. V. Korytov has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Assessment of the efficacy of fractionation regimes in chemoradiotherapy for inoperable locally advanced pancreatic cancer

    by Yu. N. Vinogradova, L. I. Korytova, A. S. Butrimova, O. V. Korytov, A. V. Meshechkin, N. V. Ilyin, Ю. Н. Виноградова, Л. И. Корытова, A. С. Бутримова, О. В. Корытов, et al.

    The purpose of the study was to improve radiotherapy efficacy by optimizing fractionation regimens in patients with inoperable stage llb-lll locally advanced pancreatic cancer. Material and Methods. Treatment outcomes of 60 patients with inoperable stage llb-lll locally advanced pancreatic cancer were analyzed in a single-center comparative study with a retrospective analysis of prospectively collected clinical data. All patients received chemoradiotherapy, including 3 or more cycles of polychemotherapy (PCT) with FOLFlRlNOX or GEMCAP regimen in combination with daily split-dose radiation therapy (RT) (group A) or stereotactic radiotherapy (STRT) (group B). Results. The efficacy of daily split-dose RT was found to be higher than that of stereotactic RT Early radiation reactions corresponded to grade l-ll and were observed in both groups. lncreased levels of transaminases were the most common: in 36.7 % of patients in group A and in 46.7 % in group B (p=0.59). Nausea/vomiting was observed in 23.3 % and 40.0 %, respectively (p=0.18). An analysis of the immediate results showed that the overall rate of objective response was significantly higher in group A compared with group B (93.3 vs 70.0 %; p=0.03). However, disease progression was observed more frequently in group B than in group A patients (30.0 vs 6.7 %; p=0.042). The daily split-course regimen demonstrated significantly higher one-year (73 vs 48 %) and two-year (39 vs 15 %) overall survival rates than stereotactic RT (pConclusion. Our study demonstrated the use of combination therapy in a carefully selected group of patients with inoperable stage llb-lll locally advanced pancreatic cancer. This type of therapy allows for increased life expectancy, overall survival, and objective response rates. Moreover, continuous improvements in radiation therapy techniques help reduce the incidence of early systemic radiation reactions. Thus, the daily split-dose dose RT is more effective and can be considered the preferred RT regimen for the treatment of inoperable patients with locally advanced pancreatic cancer.

  • Open Access

    Value of Radiotherapy in Complex Treatment of Locally Advanced Pancreatic Cancer

    by Yu. N. Vinogradova, L. I. Korytova, A. S. Butrimova, O. V. Korytov, A. V. Meshechkin, N. V. Ilyin

    Purpose: To familiarize radiation oncologists and specialists of related specialties with various aspects of a promising, comprehensive approach to patients with locally advanced pancreatic cancer.Materials and methods: The review includes data from domestic and foreign articles found in PubMed/MEDLINE, as well as a clinical case.Results: As a clinical example, patients with locally advanced pancreatic cancer who received chemotherapy followed by radiation therapy are presented, and the immediate results of treatment are demonstrated.Conclusions: Despite the predominant role of chemotherapy and surgery in the treatment of pancreatic cancer, radiation therapy still plays an important role in the comprehensive treatment of this disease as a method that improves local control in resectable, borderline resectable, locally advanced, and recurrent pancreatic cancer. However, there is a lack of data on the methods, target volume determination, and fractionation schemes.

  • Open Access

    Diagnostic of Radiation Induced Cystitis by PET-CT. Experimental Study

    by Олег Витальевич Корытов, Луиза Ибрагимовна Корытова, Андрей Алексеевич Станжевский, Михаил Иосифович Школьник, Валентина Петровна Сокуренко, Денис Георгиевич Прохоров

    Введение. Лучевая терапия на современном этапе развития медицины является одним из четырех составляющих успешного лечения в онкологии. Однако в процессе облучения неизбежно поражается не только опухолевая масса, но и окружающие здоровые органы и ткани. При облучении органов малого таза критическим и наиболее поражаемым органом, который чувствителен даже к низким дозам радиации, является мочевой пузырь. Признаки острого радиационно-индуцированного цистита (РИЦ) могут недооцениваться, и, следовательно, информация о них может не фиксироваться в медицинских документах, в то время как у пациентов на этом фоне развиваются поздние радиационно-индуцированные поражения мочевого пузыря. Поздние РИЦ являются результатом продолжающихся процессов повреждения тканей мочевого пузыря и иммуногистологических изменений как следствие неполноценного репаративного ответа. Поздние осложнения лучевой терапии малого таза составляют до 7 % экстренных госпитализаций в урологические клиники. Цель. Установить роль позитронной эмиссионной томографии, совмещённой с компьютерной томографией (ПЭТ-КТ) в диагностике перехода лучевых реакций в поздние повреждения мочевого пузыря в эксперименте. Материалы и методы. В исследование включено 48 экспериментальных животных, которым предварительно был смоделирован острый РИЦ. ПЭТ-КТ исследование проводили до начала и через 9 дней после окончания лечения РИЦ. В качестве РФП вводили холин, меченый 11С, в объеме 0,4-1,0 мл на 100 гр массы тела животного. Для оценки хронизации острого РИЦ использовали величину площади поражения S (мм2) и интенсивность накопления РФП в SUV в стенках мочевого пузыря. Результаты. Результаты повторных ПЭТ-КТ позволили сформировать прогноз на выздоровление или на хронизацию РИЦ. После вскрытия установлено, что у 16 из 17 животных с хорошим прогнозом, но без дополнительной терапии признаков цистита не обнаружено (94,3 %), а с продолженной терапией признаки цистита отсутствовали в 100 % случаев. У 13 животных с плохим прогнозом по данным ПЭТ-КТ, хронический цистит был зафиксирован в 100 % и подтвержден гистологически. Выводы. 1. ПЭТ-КТ с использованием холина, меченного 11С, является прогностически достоверным для оценки вероятности хронизации РИЦ у экспериментальных животных. 2. Изменение одного из показателей S на 15-20 %, либо SUV на 15 %, либо стабилизация любого из этих показателей является прогностическим признаком хронизации РИЦ.


  • Open Access

    Study of the risks of radiation induced reactions in patients receiving irradiation of the pelvic organs

    by O. V. Korytov, L. I. Korytova, S. G. Grigorjev

    Background. The oncological incidence in the world and the Russian Federation of rectal cancer (RC), prostate cancer (PC) and cervical cancer (CC) over the past 10–15 years remains high, with overall incidence of the pelvic organs cancer up to 25 % of the total. Radiation therapy is included in the complex of therapeutic measures in 50–70 % of cancer patients. The main feature of radiation therapy of patients with malignant neoplasms is the effect on both tumor and healthy cells of surrounding tissues. The development of radiation damage to healthy tissues, expressed in radiation reactions (RR) and complications lead to a deterioration in the quality of life. Unfortunately, it is currently not possible to predict which of the patients will develop radiation injuries above grade 1 and at what time.Aim. To assess the risks of RR in patients with diagnoses of RC, prostate cancer and cervical cancer who underwent radiation therapy.Materials and methods. The study included 759 patients, including 387 CC, 175 PC, and 197 RC, who received radiation therapy from 2011 to 2019 in the medical institutions of St. Petersburg and the Leningrad region.Results. More than 30 factors that characterized patients, tumor features and concomitant therapy options were studied. Twelve of them turned out to be significant. In order to establish the main determinants (factors) associated with the risk of radiation reactions, a discriminant analysis was carried out. A formula has been created to calculate the probability of developing RR. We conducted an additional study on changing the timing of the introduction of hydrogel compositions, in which a decrease in the frequency of radiation-induced cystitis was noted.Conclusion. Discriminant analysis revealed predictors of RR in patients with RC, CC, and PC out of 30 factors studied. From the results of discriminant analysis, formulas for predicting the probability of developing acute RR in patients with diagnoses of RC, CC, and PC who received radiation therapy were derived. The change in the time of administration of hydrogel compositions before, during and after the end of radiation therapy contributed to a decrease in the occurrence of radiation-induced cystitis compared with the control (р 0.05).


  • Open Access

    Radiation induced cystitis prophylactics and treatment with hydrogel compositions in rectal cancer patients: a retrospective study

    by O. V. Korytov, L. I. Korytova

    INTRODUCTION: The incidence of rectal cancer in different countries tends to increase over the past 10 years. In the Russian Federation, the incidence of rectal cancer accounts for about 4.5% of the total oncological incidence, where stage III–IV is 25.9% and 23%, respectively. In the light of current trends, national clinical guidelines from different countries recommend starting the treatment of locally advanced rectal cancer with radiation or chemoradiotherapy. Radiation therapy is usually accompanied by radiation reactions and complications. For the last 10–15 years, hydrogel compositions have been included in the treatment of radiation reactions along with basic drugs.OBJECTIVE: To study the effect of the use of hydrogel compositions for the prevention and treatment of radiation reactions during irradiation of patients with rectal cancer.MATERIALS AND METHODS: The study included 257 patients, including 146 men and 111 women aged 27 to 88 years, the median was 59 years old, who lived in St. Petersburg, the Leningrad Region and in other regions of the Russian Federation, who received radiation therapy since 2013 to 2019 for rectal cancer. The severity of radiation reactions was assessed by the current RTOG/EORTC. Basic drug therapy, including non-steroidal anti-inflammatory drugs, antispasmodics, hemostatic agents, oil mixtures, etc., was used in 47% of patients. In the course of radiation therapy, 35 patients were prescribed hydrogel-based composite preparations with derinat, dioxidine and lidocaine.Statistics: Data processing was carried out using the Excel spreadsheet editor, as well as the Statistica 10 for Windows statistical data processing software package.RESULTS: Radiation proctitis was registered in 81 (31.5%), dermatitis in 50 (19.5%), cystitis in 45 (17.5%), enterocolitis, enteritis or colitis in 28 (10.9%), hematological toxicity in 8 (3.1%), vaginitis in 8 (3.1%), other in 7 (2.7%) patients. Taking into account that the bladder is the most frequently irradiated organ in cases where the target tumor is localized in adjacent organs of the small pelvis, as well as the lack of prevention and treatment standards (golden standard), radiation cystitis, which poisons the lives of apparently healthy patients, was carried out study of the effect of hydrogel compositions in the appointment of these drugs before, during and after the end of radiation therapy compared with the control. In the study group, a later onset of cystitis was noted (with SD from 20 to 34 Gy), the frequency of cystitis was 9% (pDISCUSSION: The impact of radiation reactions and complications on the quality of life of rectal cancer patients is actively discussed in the Russian Federation and abroad. At the same time, the incidence of rectal cancer in the world is growing, as well as the need for radiation therapy. Radiation cystitis is a recognized complication of radiation therapy of the pelvic organs. The frequency of RIC, according to various authors, ranges from 23 to 80%. Hydrogel compositions are one of the proven effective means of combating radiation damage.CONCLUSION: the presence of radiation reactions during pre/postoperative radiation therapy for rectal cancer significantly contributes to a decrease in the five-year survival rate of patients. The frequency of radiation cystitis significantly decreases against the background of the appointment of hydrogel compositions before, during and after radiation therapy.

  • Open Access

    Influence of late radiation complications on long-term survival of patients treated with irradiation of the pelvic organs

    by O. V. Korytov

    Background. Radiation therapy is one of the main treatments for locally advanced cancers of the rectum, cervix, and prostate. As a result of summing up high total doses, radiation damage occurs in patients.Aim. To determine the frequency of late radiation injuries in patients, their impact on overall survival and quality of life.Materials and methods. The study included 759 patients who received treatment in medical facilities in St. Petersburg and the Leningrad Region, of which 324 were men and 435 were women aged 27–88 years, with a diagnosis of rectal cancer – 257, cervical cancer – 327, prostate cancer – 175 patients. Irradiation was carried out on linear accelerators and brachytherapy devices. The quality of life of patients was assessed by questionnaires based on QLQ-30.Results. The overall toxicity was 35.01 % in patients with cervical cancer, 10.4 % in patients with rectal cancer and 7.6 % in patients with prostate cancer. Overall long-term 5 and 10 years survival in patients with late complications was 46.3 and 16.5 % versus 66.5 and 33.4 % in patients without late complications (p = 0.001). In patients diagnosed with rectal cancer, it was significantly higher than in other groups (p 0.05). 3–5 weeks after the end of radiation therapy, patients reported a significant deterioration in the quality of life.Conclusion. Late radiation damage is an important prognostic factor influencing long-term survival in patients diagnosed with cancer of the rectum, cervix and prostate. A decrease in the quality of life in patients who received irradiation of the pelvic organs 3–5 weeks after the end of radiation therapy has been proven.


  • Open Access

    Evaluation of the Efficacy of Neoadjuvant Radiation Twice a Day Fractionation Therapy in Patients with Resectable Pancreatic Head Cancer

    by L. I. Korytova, D. A. Sklyar, E. V. Vlasova, A. V. Pavlovskiy, A. A. Polikarpov, E. V. Moiseenko, O. V. Korytov

    The coronavirus of severe acute respiratory syndrome-2 (SARS-CoV-2) and the coronavirus infection caused by it, along with damage to the respiratory system, can lead to disorders of the central and peripheral nervous system. The article presents literature data and own observations of neurological disorders in patients with coronavirus disease in the superacute period. Pronounced neurological disorders are mainly observed in severe coronavirus disease and include acute ischemic stroke, subcortical micro- and macro— bleeding, acute necrotizing encephalopathy, Guillain-Barre syndrome. Factors potentially complicating the course of coronavirus disease and contributing to the development of neurological complications are hypertension, diabetes mellitus, chronic diseases of the heart and respiratory system. Based on existing publications and our own observations, we have systematized information about the relationship between coronavirus disease and neurological disorders, about possible factors contributing to the occurrence of stroke. The possibilities of using chest MSCT as the only method of radiation diagnostics for the early detection of viral pneumonia in patients receiving emergency and emergency care at the regional vascular center of BUZOO «GC BSMP No. 1» are considered. The use of this method, in the ultra-acute period of acute ischemic stroke, during the first 40 minutes from the moment of admission, can significantly reduce the time of diagnosis and mortality in patients with acute ischemic stroke and viral pneumonia.


  • Open Access

    Neoadjuvant Сhemoradiotherapy of Locally Advanced Rectal Cancer with Local 5-Fluoracil Radiomodification

    by A. R. Akhtemzyanov, O. V. Korytov, L. I. Korytova, A. V. Meshechkin, N. D. Oltarzhevskaya, M. A. Korovina

    Chemoradiotherapy, along with following surgical treatment, including total mesorectal excision, is a current standard for treatment of locally advanced rectal cancer. Neoadjuvant chemoradiotherapy allows to downsize the tumor, up to complete clinical response in one third of all cases, which, in turn, allows increase in sphincter preserving operations, disease-free period and overall survivability. Derivatives of 5-fluoracil are used as basic chemotherapeutic agents. These drugs have a substantial amount of side effects, which lead to either plan corrections, or may even prevent its completion. Thus, search for new ways to increase chemotherapy agent in the tumor cells with reduction of systemic toxicity to improve neoadjuvant chemoradiotherapy results is an acute task for modern medicine. In this article authors suggest intrarectal application of sterile hydrogel material based on sodium alginate with incorporated 5-fluoracil as a method of neoadjuvant chemoradiotherapy.